U.S. pharma huge copyright scrapped two experimental weight loss drugs very last year—a as soon as-day by day pill, lotiglipron, as a consequence of elevated liver enzymes plus a twice-every day pill, danuglipron, resulting from powerful side effects—but CEO Albert Bourla has mentioned the company is decided to “play and get” during the bei